Clinical Trials Logo

Clinical Trial Summary

In this A Single-center, Prospective, Self-controlled trial, subjects should avoid a high-magnesium diet for 1-3 weeks and take magnesium supplements for 4-6 weeks.


Clinical Trial Description

Investigational drug# Oral magnesium Study title# To explore the regulatory effect of magnesium on intestinal flora in healthy adults # A Single-center, Prospective, Self-controlled trial. Principal Investigator# Professor Yu Chen, Department of Gastroenterology, The Seventh Affiliated Hospital, Southern Medical University. Professor Peng Chen, Department of Pathophysiology, School of Basic Medical Sciences, Southern Medical University. Study subjects# Healthy adult, Age 20-30 years Study phase# Investigator Initiated Trial(IIT) Study objectives# The objective of the study is to explore the regulatory effect of magnesium on intestinal flora in healthy adults Study design# A Single-center, Prospective, Self-controlled trial. Medication method# Subjects should avoid high magnesium diet for 1-3 weeks, and take magnesium supplement (food grade magnesium citrate: 1 capsule, 400mg/ capsule, three times a day, after meals) in 4-6 weeks. Peripheral blood and stool samples were collected from 60 subjects on day 0, day 21, and day 42 of the study period for routine blood tests, blood biochemical tests, and 16s rDNA sequencing analysis of gut microbiota. Course#42days Sample size#60. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05597150
Study type Interventional
Source The Seventh Affiliated Hospital, Southern Medical University
Contact
Status Completed
Phase N/A
Start date October 15, 2022
Completion date March 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT01399879 - Measuring Skin Electrical Potential With the Kelvin Probe: Minimizing Noise N/A